Table 3

Serum FAs (μmol/l) in three groups stratified by overweight or obesity*

BMI ≥25 kg/m2BMI <25 kg/m2
GDMImpaired GCT non-GDMControl subjectsGDMImpaired GCT non-GDMControl subjects
n103653394445
    Entry
        SFAs227.02 ± 16.27244.13 ± 15.32206.65 ± 14.83243.50 ± 32.62196.37 ± 16.60184.91 ± 14.47
        MUFAs116.07 ± 14.36133.66 ± 13.52108.79 ± 13.91105.37 ± 28.7873.92 ± 14.65§73.41 ± 12.78§
        PUFAs58.09 ± 6.6666.87 ± 6.2756.17 ± 6.0759.78 ± 13.3540.37 ± 6.7942.17 ± 5.92
        Total free FAs401.85 ± 34.15444.83 ± 32.16371.59 ± 31.15407.53 ± 68.51306.86 ± 34.43299.86 ± 30.41§
    Third trimester
        SFAs235.71 ± 16.80197.31 ± 14.60189.90 ± 14.21198.02 ± 28.56200.34 ± 15.21§169.29 ± 13.33
        MUFAs149.80 ± 14.30118.81 ± 12.42113.78 ± 12.1085.40 ± 24.31102.61 ± 12.9275.90 ± 11.34
        PUFAs69.47 ± 6.3156.07 ± 5.4855.98 ± 5.3345.80 ± 10.7249.84 ± 5.7§39.95 ± 5.00
        Total free FAs455.10 ± 35.00372.28 ± 30.39359.66 ± 29.59§329.41 ± 59.47351.74 ± 31.1§285.17 ± 27.76
  • Data are means ± SE.

  • *Models were adjusted for age, ethnicity, parity, and cigarette smoking;

  • P < 0.05 vs. impaired GCT non-GDM with BMI ≥25 kg/m2;

  • P < 0.01 vs. impaired GCT non-GDM with BMI ≥25 kg/m2;

  • §P < 0.05 vs. GDM with BMI ≥25 kg/m2;

  • P < 0.01 vs. GDM with BMI ≥25 kg/m2;

  • P < 0.05 vs. control subjects with BMI ≥25 kg/m2.